Helath care sell-off
Mar. 9 - Ransdell Pierson, Health Care Correspondent, and Alex Kane, Director of the Biotech team of Thomson Reuters Corporate Advisory Services discuss the Health care sector with Dan Burns.<div class="feedflare">
<img src="http://feeds2.feedburner.com/~ff/reuters/USVideoBusiness?d=yIl2AUoC8zA" border="0"></img> (http://feeds.reuters.com/~ff/reuters/USVideoBusiness?a=doXCUHOWLf4:bJZFyzhlyAU:yIl2AUoC8zA) <img src="http://feeds2.feedburner.com/~ff/reuters/USVideoBusiness?i=doXCUHOWLf4:bJZFyzhlyAU:V_sGLiPBpWU" border="0"></img> (http://feeds.reuters.com/~ff/reuters/USVideoBusiness?a=doXCUHOWLf4:bJZFyzhlyAU:V_sGLiPBpWU) <img src="http://feeds2.feedburner.com/~ff/reuters/USVideoBusiness?i=doXCUHOWLf4:bJZFyzhlyAU:F7zBnMyn0Lo" border="0"></img> (http://feeds.reuters.com/~ff/reuters/USVideoBusiness?a=doXCUHOWLf4:bJZFyzhlyAU:F7zBnMyn0Lo)
</div><img src="http://feeds2.feedburner.com/~r/reuters/USVideoBusiness/~4/doXCUHOWLf4" height="1" width="1"/>
http://feeds.reuters.com/~r/reuters/USVideoBusiness/~3/doXCUHOWLf4/video